Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old

Authors:
  • CBCarrie L. Byington
    Carrie L. Byington
  • JLJane M. Lavelle
    Jane M. Lavelle
  • PLPatricia S. Lye
    Patricia S. Lye
  • MMMichelle L. Macy
    Michelle L. Macy
Top Cited Papers
Publisher website
Google Scholar
Abstract
This guideline addresses the evaluation and management of well-appearing, term infants, 8 to 60 days of age, with fever ≥38.0°C. Exclusions are noted. After a commissioned evidence-based review by the Agency for Healthcare Research and Quality, an additional extensive and ongoing review of the literature, and supplemental data from published, peer-reviewed studies provided by active investigators, 21 key action statements were derived. For each key action statement, the quality of evidence and benefit-harm relationship were assessed and graded to determine the strength of recommendations. When appropriate, parents’ values and preferences should be incorporated as part of shared decision-making. For diagnostic testing, the committee has attempted to develop numbers needed to test, and for antimicrobial administration, the committee provided numbers needed to treat. Three algorithms summarize the recommendations for infants 8 to 21 days of age, 22 to 28 days of age, and 29 to 60 days of age. The recommendations in this guideline do not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate.

This publication has 148 references indexed in Scilit: